<h1>Company markets ECG-based catheter tip confirmation to replace routine chest X-rays, raising claims, regulatory and liability concerns</h1> A medical technology company launched a bedside catheter navigation and ECG-based tip confirmation system in India, marketed to reduce peripherally inserted central catheter (PICC) malposition and eliminate routine post-placement chest X-rays. The product is promoted as reducing confirmation time and malposition rates based on cited global clinical data; the company conducted multi-city promotional events and clinician training and offers local sales support. Legal considerations include accuracy of efficacy claims, compliance with medical device regulations and advertising rules, informed-consent and standard-of-care implications for replacing radiologic confirmation, and potential liability if performance differs from promoted outcomes.